Mitchell Nussbaum, chair of Loeb & Loeb’s Securities Practice, is featured in The Deal’s video series in an interview with The Deal’s Suzanne Stevens discussing China’s new Nasdaq-like stock exchange called ChiNext. Nussbaum says that the new market gives private equity firms and investors another exit option, often at high valuations. He also notes that there remains some uncertainty revolving around the regulatory systems and the volatility of the Chinese markets.
See Mitchell Nussbaum’s video interview on YouTube.
Mitchell Nussbaum, chair of Loeb & Loeb’s Securities Practice, represented the first Chinese, Taiwanese, Thai and Vietnamese companies to list on the American Stock Exchange. He has represented issuers and underwriters in scores of SPAC offerings and ranked #2 among IPO lawyers in IPO Vital Signs’ 2008 Leadership Rankings. His full biography is here.
Loeb & Loeb’s Corporate and Securities Practice is focused in the areas of initial and secondary public offerings; alternative public offerings (reverse mergers and SPACs); private equity (including PIPEs) corporate finance; and mergers, acquisitions and joint ventures. IPO Vital Signs ranked Loeb & Loeb #4 in the U.S. for IPO law firms representing issuers that closed in 2008; and the firm placed #7 in the U.S. for combined IPO count representing issuers and underwriters.
Loeb & Loeb’s China Practice serves Chinese based companies and U.S. clients doing business in the People’s Republic of China in the following areas: initial and secondary public offerings; alternative public offerings (SPACs and reverse mergers); corporate governance; PIPEs; private equity and debt financings; due diligence & investigative services; mergers, acquisitions and joint ventures; intellectual property matters; cross-border transactions; management compensation plans; labor and employment issues; venture capital financing; outsourcing; entertainment financing and cross-border tax structuring. Loeb & Loeb has assisted over 50 Chinese companies to list on U.S. stock exchanges.